Drug defence: designing against defects.
«Quality by Design» thinking enables drug efficacy and minimises opportunities for contamination.
2020
Securing the supply.
Navigating pharma’s packaging challenges amid a pandemic.
The Process of Pharmaceutical Elastomer Selection for Injectable Biologics.
Datwyler discusses five considerations for drug manufacturers to consider when selecting parenteral packaging for their drug products.
Preserving the parenterals of tomorrow.
Glenn Thorpe, Senior Vice President, Pharma at Datwyler, says pharmaceutical companies should engage with packaging suppliers that can meet the industry demands of the pandemic.
Drug Protection: Eliminate Defects.
In OFWeek, Datwyler discusses how to set goals for zero defects in pharmaceutical packaging manufacturing and why this is a critical process consideration, especially during a pandemic.
The Next Generation of Coated Plungers from Datwyler.
In Korean publication, Plastic Net, Datwyler’s Global Product Leader for Prefilled Syringes and Cartridges, Carina van Eester, discusses the features and benefits of Datwyler’s NeoFlex™ plungers.
Smart goals and continuos improvement for a resilient sustainability strategy.
Dirk Borghs considers the obligation of the pharmaceutical sector to implement environmentally responsible practices, and discusses the steps Datwyler is taking in its efforts for sustainability.
The Next Generation of Coated Plungers from Datwyler.
In Korean Packaging Association, Datwyler’s Global Product Leader for Prefilled Syringes and Cartridges, Carina van Eester, discusses the features and benefits of Datwyler’s NeoFlex™ plungers.
Injection Devices: Will COVID-19 Deliver Growth to the Market?
In May, Project Jumpstart, a public-private initiative, was announced that will pump $138 million into the production of 100 million prefilled syringes by the end of this year and another 500 million in 2021, should a COVID-19 vaccine become available. Yet, industry gurus do not necessarily agree that the pandemic will have a positive impact on the injection delivery market. Datwyler’s Global Platform Leader for Prefilled Syringes and Cartridges, Carina van Eester, discusses the important role that coated plungers play in ensuring the appropriate functionality and compatibility of injection devices.
Achieving Zero Defects in a Pandemic.
When Lives and Livelihoods Depend on Accelerating Large Molecule Drug Production, Biopharma Companies must Minimize Defects and Contamination» says Massimo Mainetti, Global Head of Marketing and Product Management, Datwyler.
«Aiming for Perfection in a Pandemic», an opinion by Datwyler.
«When Lives and Livelihoods Depend on Accelerating Large Molecule Drug Production, Biopharma Companies must Minimize Defects and Contamination» says Massimo Mainetti, Global Head of Marketing and Product Management, Datwyler.
The next generation of coated plungers.
Carina Van Eester explores the benefits of fully coated plungers for prefilled syringes and cartridges.
Prefilled Syringes & Parenteral Manufacturing: Innovations, Challenges & Solutions.
Plunger Designed with Functionality in Mind.
Innovating Drug Delivery to Carry Us to the ‘New Normal’.
The growth of injectables, personalized medicine, anti-counterfeiting measures, and automation are a few trends that may follow the industry into a new normal.
How the drug delivery systems market is changing.
Rahul Thakar, PhD, technical key account manager at Datwyler Pharma, discusses the rise of injectables, quality control measures, and personalization.
Datwyler launches spray-coated plungers to minimise leachables.
Datwyler has launched its NeoFlex plungers to help developers better protect the integrity of injectable formulations and optimise the functionality of prefilled syringes and cartridge.
2019
Ensuring Container Closure Integrity through a Parenteral Packaging System Approach.
Container closure integrity (CCI) is an increasingly relevant issue in the pharmaceutical packaging industry. It addresses the maintenance of integrity to prevent microbial ingress in sterile product packaging until the time of use, as well as to restrict the loss of product contents and to prevent the entry of detrimental gases or other materials.
Elastomer manufacturing: primary packaging for parenteral drugs.
With the advent of biologics and highly sensitive drugs, primary packaging materials must meet the highest-level of functional, regulatory and cleanliness standards to ensure compatibility and ultimately, patient safety. Rahul Thakar, PhD, discusses Datwyler's solution to these ever-stricter requirements is their highest-quality manufacturing standard, FristLine™.